Skip to main content
Figure 3 | BMC Cancer

Figure 3

From: MiR-125b promotes proliferation and migration of type II endometrial carcinoma cells through targeting TP53INP1 tumor suppressor in vitro and in vivo

Figure 3

Effect of miR-125b on cell migration of AN3CA cells after differential treatment in vitro wound healing assay. Ishikawa cells were seeded in 6-well plates and wounding on the next day. Photographs were taken at hour 0, 24, and 48 h, respectively, after the wound was made. Ishikawa cells transfected with miR-125b, but not miR-125bm NC and untransfected group, closed the wound at 48 h after incubation.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us